Dr. Agarwal's Eye Hospital Limited (BOM:526783)
India · Delayed Price · Currency is INR 5,150.75
+63.30 (1.24%)
At close: May 22, 2026
BOM:526783 Revenue
In the fiscal year ending March 31, 2026, Dr. Agarwal's Eye Hospital had annual revenue of 4.77B INR with 20.03% growth. Dr. Agarwal's Eye Hospital had revenue of 1.22B in the quarter ending March 31, 2026, with 21.79% growth.
Revenue
4.77B
Revenue Growth
+20.03%
P/S Ratio
5.22
Revenue / Employee
3.80M
Employees
1,255
Market Cap
24.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 4.77B | 795.40M | 20.03% |
| Mar 31, 2025 | 3.97B | 778.50M | 24.38% |
| Mar 31, 2024 | 3.19B | 512.00M | 19.10% |
| Mar 31, 2023 | 2.68B | 668.90M | 33.24% |
| Mar 31, 2022 | 2.01B | 608.84M | 43.39% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ddev Plastiks Industries | 29.21B |
| Federal-Mogul Goetze (India) | 19.49B |
| Thirumalai Chemicals | 18.34B |
| Hikal | 17.46B |
| Yasho Industries | 8.31B |
| Monarch Networth Capital | 3.66B |
| Elcid Investments | 1.80B |
| The Orissa Minerals Development Company | 718.23M |
Dr. Agarwal's Eye Hospital News
- 21 days ago - ‘Pinhole pupilloplasty can be corneal transplant alternative’ - The Times of India
- 3 months ago - Doctors at private hospital restore vision to Mumbai medico blinded in both eyes - The Times of India
- 1 year ago - Eye hospital hosts ophthalmology workshop - The Times of India